Home Medicine Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study
Article
Licensed
Unlicensed Requires Authentication

Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study

  • Fabrizia Bamonti , Cristina Novembrino , Silvia Ippolito , Enzo Soresi , Alberto Ciani , Silvia Lonati , Elisabetta Scurati-Manzoni and Giuliana Cighetti
Published/Copyright: September 21, 2011

Abstract

Background: Cigarette smoking, a cardiovascular risk factor leading to oxygen free radical formation, is involved in the development of serious pathological conditions. On the other hand, a healthy diet and adequate supplementation can help prevent many diseases. The aim of our study was to evaluate in healthy light smokers the effects of supplementation with mixed fruit and vegetable juice powder concentrate on homocysteine metabolism and oxidative status.

Methods: In this pilot study, 32 healthy volunteers, 16 light smokers and 16 non-smokers, on twice daily supplementation were monitored at time zero and after 30days. Plasma homocysteine, and serum vitamin B12 and folate concentrations were measured by immunoenzymatic assays; reactive oxygen species, total antioxidant capacity and thiol groups by spectrophotometric methods; and total and free malondialdehyde concentrations by gas chromatography-mass spectrometry with isotopic dilution.

Results: Baseline free malondialdehyde concentrations were significantly higher in smokers than in non-smokers and normalised after 30-day supplementation. Baseline results for all the other parameters remained unchanged after supplementation, with no significant differences between smokers and non-smokers.

Conclusion: This is the first study showing a significant decrease in free malondialdehyde levels in light smokers after 1-month phytonutrient supplementation.


Corresponding author: Fabrizia Bamonti, Dipartimento Scienze Mediche, Università degli Studi di Milano, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Fondazione IRCCS, Padiglione Granelli, Via F. Sforza, 35, 20122 Milano, Italy Phone: +39-02-55033473, Fax: +39-02-55034736 ,

References

1. Bray GA, Ryan DH, Harsha DW. Diet, weight loss, and cardiovascular disease prevention. Curr Treat Options Cardiovasc Med 2003; 5:259–69.10.1007/s11936-003-0025-9Search in Google Scholar

2. Morris CD, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of evidence for the US Preventive Service Task Force. Ann Intern Med 2003; 139:56–70.10.7326/0003-4819-139-1-200307010-00014Search in Google Scholar

3. Trotti R, Carratelli M, Barbieri M, Micieli G, Bosone D, Rondanelli M, et al. Oxidative stress and thrombophilic condition in alcoholics without severe liver disease. Haematologica 2001; 86:85–91.Search in Google Scholar

4. Carratelli M, Porcaro L, Ruscica M, De Simone E, Bertelli AA, Corsi MM, et al. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome. Int J Clin Pharm Res 2001; 21:79–84.Search in Google Scholar

5. Stanger O, Herrmann W, Pietrzik K, Fawler B, Geisel J, Dierkes J, et al. DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 2003; 41:1392–403.10.1515/CCLM.2003.214Search in Google Scholar

6. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3:276–85.10.1038/nrc1046Search in Google Scholar

7. Fracchiolla NS, Bamonti-Catena F, Novembrino C, Ippolito S, Maisonneuve P, Cortelezzi A. Possible association between reactive oxygen metabolites and karyotypic abnormalities in myelodysplastic syndromes. Haematologica 2003; 88:594–7.Search in Google Scholar

8. Campise M, Bamonti F, Novembrino C, Ippolito S, Tarantino A, Cornelli U, et al. Oxidative stress in kidney transplant patients. Transplantation 2003; 76:1474–8.10.1097/01.TP.0000090344.61975.F0Search in Google Scholar

9. Bounous G, Molson JN. The antioxidant system. Anticancer Res 2003; 23:1411–5.Search in Google Scholar

10. Evans P, Halliwell B. Micronutrients: oxidant/antioxidant status. Br J Nutr 2001; 85(Suppl 2):S67–74.10.1079/BJN2000296Search in Google Scholar

11. Draper HH, Csallany AS, Hadley M. Urinary aldehydes as indicators of lipid peroxidation in vivo. Free Radical Biol Med 2000; 29:1071–7.10.1016/S0891-5849(00)00367-1Search in Google Scholar

12. Esterbauer H, Schaur RJ, Zoller H. Chemistry and biochemistry of 4-hydroxynonenal and malondialdehyde and related aldehydes. Free Radical Biol Med 1991; 11:81–128.10.1016/0891-5849(91)90192-6Search in Google Scholar

13. Cighetti G, Debiasi S, Paroni R, Allevi P. Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. Anal Biochem 1999; 226:222–9.10.1006/abio.1998.2952Search in Google Scholar

14. Mangoni AA, Arya R, Ford E, Asonganyi B, Sherwood RA, Ouldred E, et al. Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial. Thromb Res 2003; 110:13–7.10.1016/S0049-3848(03)00295-0Search in Google Scholar

15. Carnevali S, Petruzzelli S, Longoni B, Vanacore R, Barala R, Cipollini M, et al. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 2003; 284:L955–63.10.1152/ajplung.00466.2001Search in Google Scholar

16. Tsiara S, Elisaf M, Mikhailidis DP. Influence of smoking on predictors of vascular disease. Angiology 2003; 54:507–30.10.1177/000331970305400501Search in Google Scholar

17. Palaniappan U, Jacobs Starkey L, O'Loughlin J, Gray-Donald K. Fruit and vegetable consumption is lower and saturated fat intake is higher among Canadians reporting smoking. J Nutr 2001; 131:1952–8.10.1093/jn/131.7.1952Search in Google Scholar

18. Clarke R, Armitage J. Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials. Cardiovasc Drugs Ther 2002; 16:411–5.10.1023/A:1022134418372Search in Google Scholar

19. Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers exposure and oxidative stress status in epidemiologic research. J Nutr 2003; 133(Suppl 3):933S–40S.10.1093/jn/133.3.933SSearch in Google Scholar

20. Polidori MC, Macocci P, Stahl W, Sies H. Cigarette smoking cessation increases plasma levels of several antioxidant micronutrients and improves resistance towards oxidative challenge. Br J Nutr 2003; 90:147–50.10.1079/BJN2003890Search in Google Scholar

21. Samman S, Sivarajah G, Man JC, Ahmad ZI, Petocz P, Caterson ID. A mixed fruit and vegetable concentrate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men. J Nutr 2003; 133:2188–93.10.1093/jn/133.7.2188Search in Google Scholar

22. Kiefer I, Prock P, Lawrence C, Wise J, Bieger W, Bayer P, et al. Supplementation with mixed fruit and vegetable juice concentrates increased serum antioxidants and folate in healthy adults. J Am Coll Nutr 2004; 23:205–11.10.1080/07315724.2004.10719362Search in Google Scholar

23. Plotnick GD, Corretti MC, Vogel RA, Hesslink R, Wise J. Effect of supplemental phytonutrients on impairment of the flow-mediated brachial artery vasoactivity after a single high-fat meal. J Am Coll Cardiol 2003; 41:1744–9.10.1016/S0735-1097(03)00302-4Search in Google Scholar

24. Panunzio MF, Pisano A, Antoniciello A, Di Martino V, Frisoli L, Cipriani V, et al. Supplementation with fruit and vegetable concentrate decrease plasma homocystine levels in a dietary controlled trial. Nutr Res 2003; 23:1221–8.10.1016/S0271-5317(03)00133-7Search in Google Scholar

25. De Vecchi AF, Patrosso C, Novembrino C, Finazzi S, Colucci P, De Franceschi M, et al. Folate supplementation in peritoneal dialysis patients with normal erythrocyte folate: effect on plasma homocysteine. Nephron 2001; 89:297–302.10.1159/000046089Search in Google Scholar PubMed

26. Cighetti G, Allevi P, Anastasia L, Bortone L, Paroni R. Use of methyl malondialdehyde as an internal standard for malondialdehyde detection: validation by isotope-dilution gas chromatography-mass spectrometry. Clin Chem 2002; 48:2266–9.10.1093/clinchem/48.12.2266Search in Google Scholar

27. Young JF, Nielsen SE, Haraldsdottir J, Daneshvar B, Lauridsen ST, Knuthsen P, et al. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am J Clin Nutr 1999; 69:87–94.10.1093/ajcn/69.1.87Search in Google Scholar PubMed

28. Bub A, Watzl B, Abrahamse L, Delincee H, Adams S, Wever J, et al. Moderate intervention with carotenoid-rich vegetable products reduces lipid peroxidation in man. J Nutr 2000; 130:2200–6.10.1093/jn/130.9.2200Search in Google Scholar PubMed

29. Leeds AR, Ferris EAE, Staley J, Ayesh R, Ross F. Availability of micronutrients from dried, encapsulated fruit and vegetable preparations: a study in healthy volunteers. J Hum Nutr Diet 2000; 13:21–7.10.1046/j.1365-277x.2000.00206.xSearch in Google Scholar

30. Van den Berg R, van Vliet T, Broekmans WM, Cnubben NH, Vaes WH, Roza L, et al. A vegetable/fruit concentrate with high antioxidant capacity has no effect on biomarkers of antioxidant status in male smokers. J Nutr 2001; 131:1714–22.10.1093/jn/131.6.1714Search in Google Scholar PubMed

31. Freese R, Alfthan G, Jauhiainen M, Basu S, Erlund I, Salminen I, et al. High intakes of vegetables, berries, and apples combined with a high intake of linoleic or oleic acid only slightly affect markers of lipid peroxidation and lipoprotein metabolism in healthy subjects. Am J Clin Nutr 2002; 76:950–60.10.1093/ajcn/76.5.950Search in Google Scholar PubMed

32. Reilly M, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996; 94:19–25.10.1161/01.CIR.94.1.19Search in Google Scholar PubMed

33. Dietrich M, Block G, Hudes M, Morrow JD, Norkus EP, Traber MG, et al. Antioxidant supplementation decreases lipid peroxidation biomarkers F2-isoprostanes in plasma of smokers. Cancer Epidemiol Biomarkers Prev 2002; 11:7–13.Search in Google Scholar

34. Dillon SA, Lowe GM, Billington D, Rahman K. Dietary supplementation with aged garlic extract reduces plasma and urine concentration of 8-iso-prostaglandin F2α in smoking and nonsmoking men and women. J Nutr 2002; 132:168–71.10.1093/jn/132.2.168Search in Google Scholar PubMed

35. Miller ER III, Appel LJ, Jiang L, Risby TH. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 1997; 96:1097–101.10.1161/01.CIR.96.4.1097Search in Google Scholar

36. Cighetti G, Paroni R, Marzorati S, Borotto E, Giudici R, Magnanimi G, et al. Evaluation of oxidative stress in serum of critically ill patients by a commercial assay and gas chromatography-mass spectrometry. Clin Chem 2005; 51:1515–7.10.1373/clinchem.2005.051250Search in Google Scholar PubMed

Received: 2005-7-28
Accepted: 2006-1-18
Published Online: 2011-9-21
Published in Print: 2006-4-1

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Natriuretic peptides and evidence-based quality specifications
  2. Preanalytical variability: the dark side of the moon in laboratory testing
  3. Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
  4. Hepatorenal syndrome
  5. Modified Levey-Jennings charts for calculated laboratory tests
  6. Increased free malondialdehyde concentrations in smokers normalise with a mixed fruit and vegetable juice concentrate: a pilot study
  7. The exponentially weighted moving average (EWMA) rule compared with traditionally used quality control rules
  8. Intermethod calibration of alanine aminotransferase (ALT) and γ-glutamyltransferase (GGT) results: application to Fibrotest® and Actitest® scores
  9. Comparison of TEST 1 with SRS 100 and ICSH reference method for the measurement of the length of sedimentation reaction in blood
  10. Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays
  11. Technical evaluation of the Beckman Coulter OV-Monitor (CA 125 antigen) immunoassay
  12. Erythrocyte membrane Na+,K+-ATPase and Mg2+-ATPase activities in subjects with methylenetetrahydrofolate reductase (MTHFR) 677 C→T genotype and moderate hyperhomocysteinaemia. The role of L-phenylalanine and L-alanine
  13. Matrix metalloproteinases and their inhibitors in different acute stroke subtypes
  14. Pyrosequencing protocol requiring a unique biotinylated primer
  15. Detection of antibodies against 60-, 65- and 70-kDa heat shock proteins in paediatric patients with various disorders using Western blotting and ELISA
  16. Quantitative determination of erythrocyte folate vitamer distribution by liquid chromatography-tandem mass spectrometry
  17. Time-level relationship between indicators of oxidative stress and Glasgow Coma Scale scores of severe head injury patients
  18. Stepwise strategies in analysing haematuria and leukocyturia in screening
  19. Elevation of serum cerebral injury markers correlates with serum choline decline after coronary artery bypass grafting surgery
  20. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study
  21. Release of anandamide from blood cells
  22. Rapid decrease in plasma D-lactate as an early potential predictor of diminished 28-day mortality in critically ill septic shock patients
  23. Evaluation of an immunoassay of whole blood sirolimus in pediatric transplant patients in comparison with high-performance liquid chromatography/tandem mass spectrometry
  24. Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases
  25. Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens
  26. Importance of the functional sensitivity determination of a serum hyaluronic acid assay for the prediction of liver fibrosis in patients with features of the metabolic syndrome
  27. The dilemma of invasive and non-invasive investigations for adult and paediatric non-alcoholic fatty liver disease: has the time come for a new biochemical marker?
  28. Is cystatin C a reliable renal marker in trauma?
  29. On the independence of intraindividual reference values
  30. Sixth International Symposium on Molecular Diagnostics, Graz, Austria, May 25-27, 2006
Downloaded on 30.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.084/html?lang=en
Scroll to top button